Quantcast

Latest Ranbaxy Laboratories Stories

2009-08-24 09:39:00

PRINCETON, N.J., Aug. 24 /PRNewswire/ -- Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that RLL has received approval from the U.S.

2009-08-11 17:08:00

KENILWORTH, N.J., Aug. 11 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced an agreement with Orchid Chemicals & Pharmaceuticals Ltd. and Orgenus Pharma, Inc. ("Orchid"), related to the generic manufacturing of certain formulations of CLARINEX(R) (desloratadine).

2009-08-11 08:06:00

PRINCETON, N.J., Aug. 11 /PRNewswire/ -- Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that RLL has received final approval from the U.S.

9e2ed01b1f60bac0647592f18bba85c5
2009-05-03 08:05:00

Due to manufacturing problems, India’s largest drugmaker announced Saturday the recall of an antibiotic currently being sold in the United States.

2009-05-01 18:00:00

PRINCETON, N.J., May 1 /PRNewswire/ -- Ranbaxy Pharmaceuticals Inc. (RPI) announced today that it is conducting a voluntary recall of all lots of Nitrofurantoin (Monohydrate/Macrocrystals) Capsules, USP 100 mg currently on the market in the U.S.

2009-04-02 09:20:02

The U.S.

2009-03-05 10:09:00

PRINCETON, N.J., March 5 /PRNewswire/ -- Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that RLL has received approval from the U.S.

2009-02-25 14:23:00

GURGAON, India, Feb. 25 /PRNewswire/ -- Ranbaxy has just received a letter and information indicating that all pending and approved ANDAs from Ranbaxy's Paonta Sahib facility have been added to a list maintained under a policy entitled "Application Integrity Policy" or "AIP".

2009-02-25 11:19:38

The U.S.

2008-11-11 00:00:27

Research and Markets (http://www.researchandmarkets.com/research/9681f0/india_pharmaceutic) has announced the addition of the "India Pharmaceutical Regulatory Report 2008 (with appendix)" report to their offering.